24 May 2013
Keywords: novartis, increase, fluvirin, production, swiss, drug, major
Article | 09 July 2007
Swiss drug major Novartis' vaccines division, the second largest supplier of influenza vaccines to the US market, says it plans ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 July 2007
23 May 2013
© 2013 thepharmaletter.com